Clinical Trials Browser

Phase 1 × OTHER × Cutaneous Metastases × Clear all

NCT05481658 2026-02-10

Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases

Phase 1 Recruiting

Cutaneous Metastases